Member Info for Davemcmanus

Bigal showing his agenda yet again pushing for PIs to take the open offer, which is probsbly the worst you can do at this stage.

Getting very exciting here. Directors in 40% higher with millions, big partners, undervaled against peers by a country mile, what's not to like.

You can't patent the concept as such. If it were possible every diagnostic firm would be doing so, and you'd only be able to buy certain device from one facturer, yet you can buy same products from the likes of BC, Abbot, Roche etc ... and other technological devices (smart phone for example,yet you can buy smart phone from any manufacturer, laptop concept of a portable computer)

What you can patent is the design, so just means somone can copy your design, they need to develop ig slightly different and achieve the same goal. Just shows the demand is not them and just like a University research lab, Genedrive just are there to prove a cobcept and move on to the next research project for the next 3 years funded by a grant.

Use your brain then before making stupid comments. Your logic is still flawed, so just making things up as you go along.

Franky no he wouldn't. If the FCA suspect any wrongdoing, it does not matter of you buy £10, £100, £10k, or £100k worth. How does the amount make a different if a crime has been commited, use your brain ffs. It's a bit like saying you could rob a bank but don't take more than £500 as the police won't bother looking for you, whereas if you take £500k they will come looking for you. It is the act itself that matters.

DB has taken part in the placing, he just knows it's not worth throwing £100k in this scam

Starres, Franky is correct AIHL is not tge golden goose it was portrayed to be. DB at the time said is was £45m per annum, but failed to mention the UK market is just £5m. That is very small and they've not even managed to sell thisthe UK, apart from 3 sites that took part in the trial. The demand for such a product is clearly not there, otherwise a big diagnostics firm would have developed one years ago, and nothing stopping them from doing so now if the demand was there. Govts worldwide don't just buy any diagbostic kits that come to the market, and the demand clearly has to be high for them to do. With a market size of just £5m, it clearly isn't a big problem. It is however a great product from a ethical point of view, but govts worldwide are not in the business of ethics, clearly demonstrated furing this pandemic. They will be raising again in 12-18 months.

Agree Yozzer, more chance of me getting hit by lightning lol

Franky the data reported is up until June 31st, so yes there is a small chance there have been sales from then onwards that have not been reported. However note the trading the update reports the current cash position, so any current sales wpuld have been reported as you suggest. Furthermore the cash balance is consistent with the cash balance as at March minus the burn rate, again suggesting no sales. No mentiins of any recievables either

You may have coded Preefty, but you were talking out your ass about any refinements to the webpages, suggesting the products is selling.

They make their money from the fees on the placing. If you look at the £6m placing in the RNS, it tells you GDR will get £5.6m net after fees. Fincapp are getting £400k for the privilage, plus the charges to the investors taking part in the placing.

Franky why do you still have tgis fantasy of the lack of sales is "DB downplaying things" The rampers have been saying this for months, which i've called out consistently. If there were any significant sales in the pipeline he would have known, and wouldn't have raised £10.50 and not at this pricepoint. Announcing significant sales straight after a placing, would straight away put him on the radar and prove him a fraud outright. He's not that stupid.

Sharcus you're talking out your ass. 9 million shares is 5% of the entire capital, not 0.5%. 4D has not been shorted as high as 5% ever since i invested. 0.5% is 900k shares

Suggest anyone that has a Twitter account, make your views known.

If the placing wasn't bad enough, have a look at Twitter. The CEO of Finncapp is celebrating the success of the Genedrive placing the ignorant twat. You would have thought thry would have had some common sense, kmowing full well people are down alot of money.

Well that's what you said your posts, read it again. The launches themselves will cost no more than £1.2m, the other £9m will go in the bank with the current £1.9m they have to pay them for the next 18 months ir so until they place again.

Well that's a load BS Clark. Where are youbfetting these numbers from? AIHL took just £600k to develop so why does it need 5 times as much to launch, given the initial uptaje is going to be modest anyway.

The £20k and £10k by Budd and Fowler is just an investment in securing their jobs for another 2 years minimum, so small price to pay. Don't forget they are on £400k and and £180k respectively, before bonus. If someone asked me to buy £10k of shares to secure my job on those salaries for 2 years, i wouldn't bat an eye lid. They've only bought because they have got pesered for the lack of director buys, otherwise tgey would have bought 0.

*broker not board

I doubt they will get any major sales with POC. Once again they've given to IHC to distribute. Distributors are not their to market your products, as they have a 100 others. If it was that easy, firms wouldn't be spendibg a fortune on sales and marketing. DB with his sales backround should know better than most.

Pacman it's because both the board and the company are trying to distant themselves from their failures to new PIs, hence no mention of the PCR testing on the broker note. They need to entice new PIs to take the shares from their mates at a profit, as well as the OO to existing investors to boost their coffers. Therefore they have picked figures from thin air for products which haven't even beeen launched, but said sweet FA about a product they had on the market gor 18 months.